MedTrace Logo

Naproxen Codeine in Arthroscopic Surgery

NCT01952652 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2013-09-30

No results posted yet for this study

Summary

In this study, the aim is to compare the efficacy of single dose naproxen sodium and combination of naproxen sodium-codeine phosphate on post-operative pain in adult patients undergoing arthroscopic menisectomy.Pre-emptive oral naproxen-codeine may be safely and more advantageous than naproxen alone.

Conditions

  • Arthroscopic Meniscus Surgery

Interventions

DRUG

Group N:Naproxen sodium

drug will be given 60 minutes before surgery

DRUG

Group NC :naproxen sodium codeine phosphate

drug will be given 60 minutes before surgery

Sponsors & Collaborators

  • Baskent University

    lead OTHER

Principal Investigators

  • Anis Aribogan, Prof.,MD · Baskent University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2013-06-30
Completion
2013-07-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01952652 on ClinicalTrials.gov